Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Aurélie Gautier"'
Autor:
Johannes Streffer, Valerie Treyer, Alfred Buck, Simon M. Ametamey, Milen Blagoev, Ralph P Maguire, Aurélie Gautier, Yves P. Auberson, Mark E. Schmidt, Ivan-Toma Vranesic, Baltazar Gomez-Mancilla, Fabrizio Gasparini
Publikováno v:
NeuroImage, Vol 230, Iss , Pp 117785- (2021)
Mavoglurant binds to same allosteric site on metabotropic glutamate receptor 5 (mGluR5) as [11C]-ABP688, a radioligand. This open-label, single-center pilot study estimates extent of occupancy of mGluR5 receptors following single oral doses of mavogl
Externí odkaz:
https://doaj.org/article/ade72d8efd5c49d88ff715c43ad5a8a3
Autor:
Johannes, Streffer, Valerie, Treyer, Alfred, Buck, Simon M, Ametamey, Milen, Blagoev, Ralph P, Maguire, Aurélie, Gautier, Yves P, Auberson, Mark E, Schmidt, Ivan-Toma, Vranesic, Baltazar, Gomez-Mancilla, Fabrizio, Gasparini
Publikováno v:
NeuroImage. 230
Mavoglurant binds to same allosteric site on metabotropic glutamate receptor 5 (mGluR5) as [
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9f6bdbb2fc79ec0e36a705827312c842
https://pubmed.ncbi.nlm.nih.gov/33545349
https://pubmed.ncbi.nlm.nih.gov/33545349
Autor:
Aurélie Gautier, Hanns-Christian Tillmann, Christian Bartels, Bruno Bieth, Romain Sechaud, Ivan Demin, Gordon Graham
Publikováno v:
International journal of clinical pharmacology and therapeutics. 54(6)
OBJECTIVE Indacaterol/glycopyrronium (IND/GLY) is a fixed-dose combination (FDC) of indacaterol, an inhaled long-acting β2-agonist (LABA), and glycopyrronium, an inhaled long-acting muscarinic antagonist (LAMA), developed as a maintenance bronchodil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::415f4926f6cd765119e066f6f06f5880
https://pubmed.ncbi.nlm.nih.gov/27049057
https://pubmed.ncbi.nlm.nih.gov/27049057
Autor:
Robert A. Wood, MD, R. Sharon Chinthrajah, MD, Alexander Eggel, PhD, Ivan Bottoli, MD, Aurelie Gautier, MSc, Maximilian Woisetschlaeger, PhD, Paolo Tassinari, MSc, Pablo Altman, MD
Publikováno v:
World Allergy Organization Journal, Vol 15, Iss 9, Pp 100690- (2022)
Food allergy (FA) is a growing healthcare problem worldwide and the rising prevalence in many countries can be attributed to lifestyle, environmental, and nutritional changes. Immunoglobulin E (IgE)-mediated FA is the most common form of FA affecting
Externí odkaz:
https://doaj.org/article/2d78392d3c8346e8b4a9d867777613b9
Autor:
Jordis Trischler, Ivan Bottoli, Reinhold Janocha, Christoph Heusser, Xavier Jaumont, Phil Lowe, Aurelie Gautier, Abhijit Pethe, Ralph Woessner, Hans‐Günter Zerwes, Stefan Zielen
Publikováno v:
Clinical & Translational Immunology, Vol 10, Iss 3, Pp n/a-n/a (2021)
Abstract Objective Ligelizumab is a humanised IgG1 anti‐IgE antibody that binds IgE with higher affinity than omalizumab. Ligelizumab had greater efficacy than omalizumab on inhaled and skin allergen provocation responses in mild allergic asthma. T
Externí odkaz:
https://doaj.org/article/72f107318a284f9296f58eca83ccd8dc